Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 248

    1.

    Allogeneic bone marrow transplantation, zidovudine, and human immunodeficiency virus type 1 (HIV-1) infection. Studies in a patient with non-Hodgkin lymphoma.

    Holland HK, Saral R, Rossi JJ, Donnenberg AD, Burns WH, Beschorner WE, Farzadegan H, Jones RJ, Quinnan GV, Vogelsang GB, et al.

    Ann Intern Med. 1989 Dec 15;111(12):973-81.PMID: 2512828 [PubMed - indexed for MEDLINE]Related articles

    2.

    Syngeneic bone marrow transplantation and adoptive transfer of peripheral blood lymphocytes combined with zidovudine in human immunodeficiency virus (HIV) infection.

    Lane HC, Zunich KM, Wilson W, Cefali F, Easter M, Kovacs JA, Masur H, Leitman SF, Klein HG, Steis RG, et al.

    Ann Intern Med. 1990 Oct 1;113(7):512-9.PMID: 1975487 [PubMed - indexed for MEDLINE]Related articles

    3.

    Transplantation of autologous and allogeneic bone marrow with liver from a cadaveric donor for primary liver cancer.

    Ringdén O, Söderdahl G, Mattsson J, Uzunel M, Remberger M, Hentschke P, Hägglund H, Sparrelid E, Elmhorn-Rosenborg A, Duraj F, Zetterquist H, Ericzon BG.

    Transplantation. 2000 May 27;69(10):2043-8.PMID: 10852594 [PubMed - indexed for MEDLINE]Related articles

    4.

    Low-dose total body irradiation, fludarabine, and antithymocyte globulin conditioning for nonmyeloablative allogeneic transplantation.

    Grosskreutz C, Ross V, Scigliano E, Fruchtman S, Isola L.

    Biol Blood Marrow Transplant. 2003 Jul;9(7):453-9.PMID: 12869959 [PubMed - indexed for MEDLINE]Related articles

    5.

    AIDS-related complex treated by antiviral drugs and allogeneic bone marrow transplantation following conditioning protocol with busulphan, cyclophosphamide and cyclosporin.

    Torlontano G, Di Bartolomeo P, Di Girolamo G, Angrilli F, Verani P, Maggiorella MT, Dragani A, Iacone A, Papalinetti G, Olioso P, et al.

    Haematologica. 1992 May-Jun;77(3):287-90.PMID: 1427437 [PubMed - indexed for MEDLINE]Related articles

    6.

    Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma.

    Negrin RS, Kusnierz-Glaz CR, Still BJ, Schriber JR, Chao NJ, Long GD, Hoyle C, Hu WW, Horning SJ, Brown BW, et al.

    Blood. 1995 Jun 1;85(11):3334-41.PMID: 7538824 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).

    National Toxicology Program.

    Natl Toxicol Program Tech Rep Ser. 1999 Feb;469:1-361.PMID: 12579204 [PubMed - as supplied by publisher]Related articlesFree article

    8.

    Monitoring of chimerism after allogeneic bone marrow transplantation with unmanipulated marrow by use of DNA polymorphisms.

    Suttorp M, Schmitz N, Dreger P, Schaub J, Löffler H.

    Leukemia. 1993 May;7(5):679-87.PMID: 8097800 [PubMed - indexed for MEDLINE]Related articles

    9.

    Allogeneic bone marrow transplantation for high risk non-Hodgkin's lymphoma during first complete remission.

    Nademanee AP, Forman SJ, Schmidt GM, Bierman PJ, Snyder DS, O'Donnell MR, Lipsett JA, Blume KG.

    Blut. 1987 Jul;55(1):11-8.PMID: 3300816 [PubMed - indexed for MEDLINE]Related articles

    10.

    Combined transplantation of allogeneic bone marrow and CD34+ blood cells.

    Link H, Arseniev L, Bähre O, Berenson RJ, Battmer K, Kadar JG, Jacobs R, Casper J, Kühl J, Schubert J, Diedrich H, Poliwoda H.

    Blood. 1995 Oct 1;86(7):2500-8.PMID: 7545459 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapy.

    Demirer T, Weaver CH, Buckner CD, Petersen FB, Bensinger WI, Sanders J, Clift RA, Lilleby K, Anasetti C, Martin P, et al.

    J Clin Oncol. 1995 Mar;13(3):596-602.PMID: 7884421 [PubMed - indexed for MEDLINE]Related articles

    12.

    A phase I/II trial of zidovudine, interferon-alpha, and granulocyte-macrophage colony-stimulating factor in the treatment of human immunodeficiency virus type 1 infection.

    Davey RT Jr, Davey VJ, Metcalf JA, Zurlo JJ, Kovacs JA, Falloon J, Polis MA, Zunich KM, Masur H, Lane HC.

    J Infect Dis. 1991 Jul;164(1):43-52.PMID: 1676045 [PubMed - indexed for MEDLINE]Related articles

    13.

    Circulating human immunodeficiency virus (HIV) p24 antigen-positive lymphocytes: a flow cytometric measure of HIV infection.

    Ohlsson-Wilhelm BM, Cory JM, Kessler HA, Eyster ME, Rapp F, Landay A.

    J Infect Dis. 1990 Nov;162(5):1018-24.PMID: 1977803 [PubMed - indexed for MEDLINE]Related articles

    14.

    High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy.

    Molina A, Krishnan AY, Nademanee A, Zabner R, Sniecinski I, Zaia J, Forman SJ.

    Cancer. 2000 Aug 1;89(3):680-9.PMID: 10931469 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells.

    van Besien K, Margolin K, Champlin R, Forman S.

    Cancer J Sci Am. 1997 Dec;3 Suppl 1:S54-8.PMID: 9457395 [PubMed - indexed for MEDLINE]Related articles

    16.

    Human immunodeficiency virus (HIV)-infected tumor xenografts as an in vivo model for antiviral therapy: role of alpha/beta interferon in restriction of tumor growth in nude mice injected with HIV-infected U937 tumor cells.

    Puddu P, Locardi C, Sestili P, Varano F, Petrini C, Modesti A, Masuelli L, Gresser I, Belardelli F.

    J Virol. 1991 May;65(5):2245-53.PMID: 1901915 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Detection of human immunodeficiency virus type 1 in AIDS patients using amplification-mediated hybridization analyses: reproducibility and quantitative limitations.

    Davis GR, Blumeyer K, DiMichele LJ, Whitfield KM, Chappelle H, Riggs N, Ghosh SS, Kao PM, Fahy E, Kwoh DY, et al.

    J Infect Dis. 1990 Jul;162(1):13-20.PMID: 2113072 [PubMed - indexed for MEDLINE]Related articles

    18.

    Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: a clinical and molecular analysis.

    Kanteti R, Miller K, McCann J, Roitman D, Morelli J, Hurley C, Berkman E, Schenkein D.

    Bone Marrow Transplant. 1999 Sep;24(5):473-81.PMID: 10482930 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Combined treatment with zidovudine and lymphoblast interferon-alpha in patients with HIV-related Kaposi's sarcoma.

    Baumann R, Täuber MG, Opravil M, Hirschel B, Kinloch S, Chave JP, Pletscher M, Lüthy R.

    Klin Wochenschr. 1991 May 24;69(8):360-7.PMID: 1909399 [PubMed - indexed for MEDLINE]Related articles

    20.

    Human immunodeficiency virus infection of human bone marrow stromal fibroblasts.

    Scadden DT, Zeira M, Woon A, Wang Z, Schieve L, Ikeuchi K, Lim B, Groopman JE.

    Blood. 1990 Jul 15;76(2):317-22.PMID: 1695109 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data